This content is machine translated Editorial Swiss Oncology in Motion: Video-based online training courses Educational films in various modules for medical oncologists, hematologists and oncology specialists. Oncology is on the move – research is advancing rapidly and new insights into biology and therapy are…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Basics, Genetics and Guidelines Prof. em. Dr. Richard Herrmann in conversation with PD Dr. med. Jeroen S. Goede, Head of Hematology, Head of the Center for Lymphomas and Leukemias, Kantonsspital Winterthur Video Part 1/3:… CME-Test
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Treatment Overview Prof. em. Dr. Richard Herrmann in conversation with Michael Gregor, M.D., Head of Hematology, Lucerne Cantonal Hospital Video Part 2/3: Treatment Overview CME-Test
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Key Figures for Practice and Outlook for the Future Prof. em. Dr. Richard Herrmann in conversation with Prof. Dr. med. Thorsten Zenz, Senior Physician at the Center for Hematology and Oncology, University Hospital Zurich Video Part 3/3: Key figures… CME-Test
View Post 2 min This content is machine translated Paroxysmal Nocturnal Hemoglobinuria Relief for patients due to longer infusion intervals Chronic destruction of red blood cells is characteristic of paroxysmal nocturnal hemoglobinuria. Mutations in the PIG-A gene lead to a GPI-AP deficit that results in uncontrolled complement activation. C5 complement…
View Post 9 min This content is machine translated Reactive plasmocytoses Polyclonal plasma cell proliferation in focus. Reactive plasmocytoses are rare, but then often pronounced. They must be tested against a reactive (polyclonal) and monoclonal Plasma cell proliferation can be delineated. Accurate differential diagnosis enables effective therapy.
View Post 2 min This content is machine translated Infections in oncology A common complication brought up to date Infections are common complications of systemic therapy in hematologic and oncologic patients. However, there are few uniform definitions and little information on how to effectively treat them.
View Post 3 min This content is machine translated Deposition dermatoses Amyloidoses: early detection of cutaneous symptoms crucial Amyloidoses are a rare form of deposit dermatoses caused by defective folding of proteins. Dermatological early detection is of great importance for the further course of the disease.
View Post 2 min This content is machine translated BCL-2 Inhibition The next chapter in blood cancer therapy is opened BCL-2 inhibition represents a milestone in the history of blood cancer treatment. Approved for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL), oral small molecule is now also…
View Post 2 min This content is machine translated Immune thrombocytopenia (ITP) The patient as the focus – a change of perspective For the treatment of immune thrombocytopenia (ITP), the use of thrombopoietin receptor agonists (TPO-RA) is currently under discussion. Although steroid administration as shock therapy is still the focus of therapy.
View Post 2 min This content is machine translated CAR-T cells Focus on innovative cancer therapy CAR-T cells are currently one of the most exciting developments in immunotherapy. It combines immunotherapy, cell therapy and gene therapy and could become a routine treatment in the future.
